Hepatitis B virus and renal transplantation

Harmit S. Kalia, Fabrizio Fabrizi, Paul Martin

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Hepatitis B virus (HBV) infection remains an important cause of liver disease in the renal transplant (RT) population, potentially diminishing survival. Consequences of HBV infection after RT include progression to decompensated cirrhosis and an increased risk of hepatocellular carcinoma. Although precautions initially recommended by the Centers for Diseases Control and Prevention 30 years ago have substantially reduced HBV transmission within hemodialysis units, acute HBV outbreaks continue to be reported in patients with chronic kidney disease on maintenance hemodialysis. In addition, immigration from areas of high HBV prevalence implies that HBV-infected organs with chronic kidney disease will continue to enter the RT pool. Fortunately, the advent of oral therapy for HBV infection now reduces the risk of HBV progression post-RT.

Original languageEnglish (US)
Pages (from-to)102-109
Number of pages8
JournalTransplantation Reviews
Volume25
Issue number3
DOIs
StatePublished - Jul 2011

Fingerprint

Hepatitis B virus
Kidney Transplantation
Virus Diseases
Transplants
Kidney
Chronic Renal Insufficiency
Renal Dialysis
Emigration and Immigration
Centers for Disease Control and Prevention (U.S.)
Disease Outbreaks
Liver Diseases
Hepatocellular Carcinoma
Fibrosis
Maintenance
Survival
Population

ASJC Scopus subject areas

  • Transplantation

Cite this

Hepatitis B virus and renal transplantation. / Kalia, Harmit S.; Fabrizi, Fabrizio; Martin, Paul.

In: Transplantation Reviews, Vol. 25, No. 3, 07.2011, p. 102-109.

Research output: Contribution to journalArticle

Kalia, Harmit S. ; Fabrizi, Fabrizio ; Martin, Paul. / Hepatitis B virus and renal transplantation. In: Transplantation Reviews. 2011 ; Vol. 25, No. 3. pp. 102-109.
@article{2000a263d59847da970d4b8ece58a89f,
title = "Hepatitis B virus and renal transplantation",
abstract = "Hepatitis B virus (HBV) infection remains an important cause of liver disease in the renal transplant (RT) population, potentially diminishing survival. Consequences of HBV infection after RT include progression to decompensated cirrhosis and an increased risk of hepatocellular carcinoma. Although precautions initially recommended by the Centers for Diseases Control and Prevention 30 years ago have substantially reduced HBV transmission within hemodialysis units, acute HBV outbreaks continue to be reported in patients with chronic kidney disease on maintenance hemodialysis. In addition, immigration from areas of high HBV prevalence implies that HBV-infected organs with chronic kidney disease will continue to enter the RT pool. Fortunately, the advent of oral therapy for HBV infection now reduces the risk of HBV progression post-RT.",
author = "Kalia, {Harmit S.} and Fabrizio Fabrizi and Paul Martin",
year = "2011",
month = "7",
doi = "10.1016/j.trre.2011.02.001",
language = "English (US)",
volume = "25",
pages = "102--109",
journal = "Transplantation Reviews",
issn = "0955-470X",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Hepatitis B virus and renal transplantation

AU - Kalia, Harmit S.

AU - Fabrizi, Fabrizio

AU - Martin, Paul

PY - 2011/7

Y1 - 2011/7

N2 - Hepatitis B virus (HBV) infection remains an important cause of liver disease in the renal transplant (RT) population, potentially diminishing survival. Consequences of HBV infection after RT include progression to decompensated cirrhosis and an increased risk of hepatocellular carcinoma. Although precautions initially recommended by the Centers for Diseases Control and Prevention 30 years ago have substantially reduced HBV transmission within hemodialysis units, acute HBV outbreaks continue to be reported in patients with chronic kidney disease on maintenance hemodialysis. In addition, immigration from areas of high HBV prevalence implies that HBV-infected organs with chronic kidney disease will continue to enter the RT pool. Fortunately, the advent of oral therapy for HBV infection now reduces the risk of HBV progression post-RT.

AB - Hepatitis B virus (HBV) infection remains an important cause of liver disease in the renal transplant (RT) population, potentially diminishing survival. Consequences of HBV infection after RT include progression to decompensated cirrhosis and an increased risk of hepatocellular carcinoma. Although precautions initially recommended by the Centers for Diseases Control and Prevention 30 years ago have substantially reduced HBV transmission within hemodialysis units, acute HBV outbreaks continue to be reported in patients with chronic kidney disease on maintenance hemodialysis. In addition, immigration from areas of high HBV prevalence implies that HBV-infected organs with chronic kidney disease will continue to enter the RT pool. Fortunately, the advent of oral therapy for HBV infection now reduces the risk of HBV progression post-RT.

UR - http://www.scopus.com/inward/record.url?scp=79959495777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959495777&partnerID=8YFLogxK

U2 - 10.1016/j.trre.2011.02.001

DO - 10.1016/j.trre.2011.02.001

M3 - Article

VL - 25

SP - 102

EP - 109

JO - Transplantation Reviews

JF - Transplantation Reviews

SN - 0955-470X

IS - 3

ER -